Answers are grounded in this paper and cite their sources.
Artificial Intelligence (AI) is advancing rapidly in behavioral health, promising high-quality, affordable, and accessible care. These tools are often framed as solutions to longstanding gaps in service access. At the same time, governments in the United States have increasingly turned to litigation and policy tools to regulate technology platforms as public and policy perspectives have shifted toward recognizing potential harms. This tension underscores the need for thoughtful regulatory approaches to AI, yet regulatory systems have struggled to keep pace as AI enters the behavioral health domain. This paper presents a policy case analysis of a state office of artificial intelligence that recently developed initial regulatory guidance for behavioral health. Drawing on first-hand accounts from policy leaders involved in the regulatory process, supplemented by publicly available legislation and guidance documents, the analysis reconstructs key activities, decision points, and tradeoffs underlying the guidance. We discuss three potential regulatory pathways: (1) market-based approaches with minimal regulation, (2) risk-only regulation focused on harm avoidance, and (3) risk–benefit regulation aimed at maximizing benefits while minimizing harm. The paper identifies key questions regulators face, tensions among stakeholder groups, and practical strategies one state used to develop initial regulatory guidance.
No takes yet. Share an insight, caveat, or question.
Hooley et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: